Navigation Links
Revised Cholesterol Guidelines Causes Concern Among Medical Community

Recently, the guidelines for acceptable cholesterol levels were lowered causing widespread concern in the medical community. //

Experts quoted in the British Medical Journal stated that the new guidelines suggest that millions of low-risk patients should be put on high-dose statins. Researchers say they are not ready to unleash high-dose statins on the public because there is too little research on outcomes.

"Statins are cholesterol-lowering wonder drugs that make sense for those who have already had heart disease," states Dr. Paul Zickler of DoctorSolve online pharmacy services. "But the concern with lower cholesterol level guidelines is that they significantly widen the group of people who are candidates for statins. Many patients with slightly elevated cholesterol levels may be otherwise healthy. For these people, improving diet, increasing exercise and stopping smoking can have the same effect as taking statins. And it's safer and less expensive."

Statins have been around since 1987, and there is no doubt that they can produce health benefits for many people. But the long-term effects of statins have been very poorly studied. "Prescribing a drug to a healthy person needlessly puts them at risk for a drug's side effects," says Zickler. In the case of statins, there are two very important side effects, although they are extremely rare: a muscle-wasting condition and liver damage.

This isn't the first time that cholesterol level guidelines have been lowered. Selling Sickness, written by Ray Moynihan and Alan Cassels, states, "according to the official US National Institutes of Health's cholesterol guidelines from the 1990s, thirteen million Americans might have warranted treatment with statins. In 2001, a new panel of experts rewrote those guidelines, and effectively raised that number to 36 million."

In 2004, another new panel of experts updated those guidelines again, bringing the number to 40 milli
'"/>




Page: 1 2

Related medicine news :

1. Revised Pregnancy Counselling Item Still Flawed
2. Royal College Issues Revised Guidelines for Face Transplantation
3. Government Allot More Funds for Revised TB Program
4. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
5. Eating More Often May Help Lower Cholesterol
6. Caution On Use of Cholesterol Drugs
7. High Cholesterol linked to Alzheimer’s diseas
8. Cholesterol Drug Helps After Angioplasty
9. Cholesterol lowering drugs increase neuropathy risk
10. Almonds Improve Cholesterol
11. Cholesterol-lowering therapy benefits older people also
Post Your Comments:
(Date:12/5/2009)...NSA new three-drug combination has shown in a phas...ve regimen" in the treatment of patients newly dia...ood cells in bone marrow, say researchers from Dan...r better were seen in all of the 66 patients treat...tudy, with 74 percent having a "very good partial ...
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2
...ng is a statement of Matthew L. Myers, President, ...p://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOG...auds U.S. Senator Jeff Merkley (D-OR) for his lead...cts, including the authority to crack down on toba...
...ng is a Statement of Matthew L. Myers President, C...://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO...uds U.S. Senator Sherrod Brown (D-OH) for his lead...cts, including the authority to crack down on toba...
...ng is a statement of Matthew L. Myers, President, ...p://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOG...auds U.S. Senator Christopher Dodd (D-CT) for his ...roducts, including the authority to crack down on ...
...hore University HealthSystem Researcher reports in... Evanston, IL (Vocus) May 20, 2009 -- A... authored by David J. Winchester , FACS, M.D., Ch... nodes may not need a radical lymph node surgery. ...
...alance, Inc. (Nasdaq: SMBL ) today held its Annu... , Smart Balance Chairman and CEO Stephen Hughes ... and growth plans for the future. "Over the past ...es said. "We are excited as ever about the future...
...iation of Flight Attendants-CWA (AFA-CWA) today te...ose after a recent public health emergency and the...use of Representatives Subcommittee on Aviation co...elieve that we must be given the tools and ability...
Other Medicine News:Health News:Sen. Jeff Merkley Votes to Protect America's Kids From Tobacco 2Health News:Sen. Jeff Merkley Votes to Protect America's Kids From Tobacco 3Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 2Health News:Sen. Sherrod Brown Votes to Protect America's Kids from Tobacco 3Health News:Sen. Christopher Dodd Leads Fight to Protect America's Kids From Tobacco 2Health News:Sen. Christopher Dodd Leads Fight to Protect America's Kids From Tobacco 3Health News:Breast Cancer Patients May be Spared Additional Surgery 2Health News:Breast Cancer Patients May be Spared Additional Surgery 3Health News:Association of Flight Attendants-CWA Testifies on Emergency Planning After Recent Flu Outbreak 2
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 1Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 3ReBuilder Medical Technologies Inc Announces New York Marketing Agreement 55421 1ReBuilder Medical Technologies Inc Announces New York Marketing Agreement 55421 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 1PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 2PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 55418 3
...d Acetaldehyde Levels in Subset of,Subjects with I..., Nov. 11 Raptor,Pharmaceuticals Corp. ("Raptor" ...y announced positive results in its Phase IIa stud...th ALDH2 deficiency, or ethanol,intolerance, as th...ogram.,Convivia(TM) is Raptor,s proprietary oral f...
...es patient screening for enrollment, SOUTH SAN FR...nc. (Nasdaq: RIGL ) today announced that the prev...ial of R788 (fostamatinib,disodium), the company,s...vember 2008 issue of Arthritis and Rheumatism. The...tis with a syk kinase inhibitor: A,twelve-week, ra...
Other Medicine Technology:Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 2Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 3Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 4Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program 5Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism 2Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism 3
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: